Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GZMO -- Ignore unavailable to you. Want to Upgrade?

To: tuck who wrote (412)	1/2/2002 3:11:09 PM
From: Extra Pale	Read Replies (2) \| Respond to of 438

$32million goes a long ways towards reducing my concern regarding gzmo's cash position - was concerned that they might do a highly dilutive share offering. This also indicates to me that genz is highly committed to gzmo projects because they came up with cash in a timely manner after apparently failing to gain upfront cash via outside collaborations. As a tracking stock, gzmo has certain advantages (like papa genz cash) that other development stage bios lack. Of course, I dont trust papa genz at all.... (anyone remember gztc?)